GLP-1 vs older weight-loss pills: an honest comparison

If you are looking at weight-loss medicines, two big families come up. The new one is the GLP-1 receptor agonists, the injectables like semaglutide (Wegovy), tirzepatide (Zepbound) and liraglutide (Saxenda). The older one is the pills, like orlistat, phentermine, phentermine/topiramate (Qsymia) and naltrexone/bupropion (Contrave). People hear the big GLP-1 numbers and assume the new drugs are simply better and the old pills are now useless. This guide gives you the honest head-to-head, because the choice is not that simple. The GLP-1 drugs produce far more weight loss in trials, but they are injectable (except oral semaglutide, sold as Rybelsus for diabetes), they are very expensive, and they have their own gut, muscle and gallbladder risks. The older pills are oral, cheaper and have been used for many years, but their effect is modest, and each carries its own real risks, from heart and dependence issues to birth defects and seizures. In India, what you can actually get shapes the choice heavily: orlistat is widely available, liraglutide has some options, semaglutide and tirzepatide are costly branded imports, phentermine is restricted, and Qsymia and Contrave are not standard here. Please talk to your doctor before any medicine decision.